Total submissions: 29
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079202 | SCV000111071 | benign | not specified | 2016-04-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000132165 | SCV000187242 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000132165 | SCV000292072 | benign | Hereditary cancer-predisposing syndrome | 2014-11-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079202 | SCV000305114 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000144668 | SCV000407071 | benign | Li-Fraumeni syndrome 1 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV000034639 | SCV000605416 | benign | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Intelligene |
RCV000144668 | SCV000611723 | benign | Li-Fraumeni syndrome 1 | 2017-08-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000300782 | SCV000629789 | benign | Li-Fraumeni syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000144668 | SCV001440886 | benign | Li-Fraumeni syndrome 1 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000034639 | SCV001940208 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17719241, 22289634, 23729685, 22703879, 18990008, 22524816, 20128691, 12459171, 19657731, 15138483, 21323870, 18426989, 15183530, 20587514, 18256523, 19789321, 15131588, 19837266, 18567547, 23210739, 22189267, 21038427, 20019240, 23073555, 20939739, 19357867, 19521721, 20886596, 21931130, 21454683, 21814224, 22336889, 19542078, 16258005, 11983757, 19657586, 11844595, 22367371, 21245379, 9891044, 17403527, 18583979, 12567188, 19171829, 19165225, 19639206, 21124037, 23207172, 21778786, 24728327, 21283750, 22545084, 24747975, 12826609, 19470478, 8625447, 23793604, 27153395, 25896519, 15609317, 23683469, 9607760) |
National Health Laboratory Service, |
RCV002225263 | SCV002505076 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Genetics Program, |
RCV002225263 | SCV002515178 | benign | Hereditary breast ovarian cancer syndrome | 2021-11-01 | criteria provided, single submitter | research | |
Genome- |
RCV000132165 | SCV002582428 | benign | Hereditary cancer-predisposing syndrome | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000144668 | SCV002583090 | benign | Li-Fraumeni syndrome 1 | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496335 | SCV002804833 | benign | Adrenocortical carcinoma, hereditary; Familial cancer of breast; Glioma susceptibility 1; Bone osteosarcoma; Li-Fraumeni syndrome 1; Nasopharyngeal carcinoma; Carcinoma of pancreas; Choroid plexus papilloma; Basal cell carcinoma, susceptibility to, 7; Hepatocellular carcinoma; Colorectal cancer; Bone marrow failure syndrome 5 | 2021-12-20 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000300782 | SCV004823832 | benign | Li-Fraumeni syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000034639 | SCV005251488 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000013144 | SCV000033391 | benign | CODON 72 POLYMORPHISM | 2009-10-01 | no assertion criteria provided | literature only | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034639 | SCV000043503 | no known pathogenicity | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Benign. |
ITMI | RCV000079202 | SCV000086398 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Pathway Genomics | RCV000144668 | SCV000189999 | uncertain significance | Li-Fraumeni syndrome 1 | 2014-07-24 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000079202 | SCV000692094 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000144668 | SCV000733710 | benign | Li-Fraumeni syndrome 1 | no assertion criteria provided | clinical testing | ||
Institute of Medical Sciences, |
RCV001255631 | SCV001432167 | pathogenic | Lip and oral cavity carcinoma | 2019-04-30 | no assertion criteria provided | research | |
Clinical Genetics Laboratory, |
RCV000079202 | SCV001905760 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000079202 | SCV001928733 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000079202 | SCV001957163 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000079202 | SCV001974193 | benign | not specified | no assertion criteria provided | clinical testing | ||
Dr. |
RCV002510562 | SCV002820082 | benign | Acute myeloid leukemia | no assertion criteria provided | clinical testing |